Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The molecular phenotype of kidney transplants.

Halloran PF, de Freitas DG, Einecke G, Famulski KS, Hidalgo LG, Mengel M, Reeve J, Sellares J, Sis B.

Am J Transplant. 2010 Oct;10(10):2215-22.

PMID:
20931695
2.

Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets.

Mueller TF, Einecke G, Reeve J, Sis B, Mengel M, Jhangri GS, Bunnag S, Cruz J, Wishart D, Meng C, Broderick G, Kaplan B, Halloran PF.

Am J Transplant. 2007 Dec;7(12):2712-22. Epub 2007 Oct 17.

3.

The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course.

Mengel M, Chang J, Kayser D, Gwinner W, Schwarz A, Einecke G, Broecker V, Famulski K, de Freitas DG, Guembes-Hidalgo L, Sis B, Haller H, Halloran PF.

Am J Transplant. 2011 Apr;11(4):708-18. doi: 10.1111/j.1600-6143.2010.03339.x. Epub 2010 Nov 29.

4.

Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies.

Hidalgo LG, Sellares J, Sis B, Mengel M, Chang J, Halloran PF.

Am J Transplant. 2012 May;12(5):1180-91. doi: 10.1111/j.1600-6143.2011.03970.x. Epub 2012 Mar 5.

5.

An integrated view of molecular changes, histopathology and outcomes in kidney transplants.

Halloran PF, de Freitas DG, Einecke G, Famulski KS, Hidalgo LG, MengeL M, Reeve J, Sellares J, Sis B.

Am J Transplant. 2010 Oct;10(10):2223-30.

PMID:
20931696
6.

Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.

Sis B, Halloran PF.

Curr Opin Organ Transplant. 2010 Feb;15(1):42-8. doi: 10.1097/MOT.0b013e3283352a50. Review.

PMID:
20009933
7.

Molecular correlates of renal function in kidney transplant biopsies.

Bunnag S, Einecke G, Reeve J, Jhangri GS, Mueller TF, Sis B, Hidalgo LG, Mengel M, Kayser D, Kaplan B, Halloran PF.

J Am Soc Nephrol. 2009 May;20(5):1149-60. doi: 10.1681/ASN.2008080863. Epub 2009 Apr 23.

8.

NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.

Hidalgo LG, Sis B, Sellares J, Campbell PM, Mengel M, Einecke G, Chang J, Halloran PF.

Am J Transplant. 2010 Aug;10(8):1812-22. doi: 10.1111/j.1600-6143.2010.03201.x.

9.

FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes.

Bunnag S, Allanach K, Jhangri GS, Sis B, Einecke G, Mengel M, Mueller TF, Halloran PF.

Am J Transplant. 2008 Jul;8(7):1423-33. doi: 10.1111/j.1600-6143.2008.02268.x.

10.

Comparing microarray versus RT-PCR assessment of renal allograft biopsies: similar performance despite different dynamic ranges.

Allanach K, Mengel M, Einecke G, Sis B, Hidalgo LG, Mueller T, Halloran PF.

Am J Transplant. 2008 May;8(5):1006-15. doi: 10.1111/j.1600-6143.2008.02199.x.

11.

Loss of solute carriers in T cell-mediated rejection in mouse and human kidneys: an active epithelial injury-repair response.

Einecke G, Kayser D, Vanslambrouck JM, Sis B, Reeve J, Mengel M, Famulski KS, Bailey CG, Rasko JE, Halloran PF.

Am J Transplant. 2010 Oct;10(10):2241-51. doi: 10.1111/j.1600-6143.2010.03263.x.

12.

Interferon-gamma and donor MHC class I control alternative macrophage activation and activin expression in rejecting kidney allografts: a shift in the Th1-Th2 paradigm.

Famulski KS, Sis B, Billesberger L, Halloran PF.

Am J Transplant. 2008 Mar;8(3):547-56. doi: 10.1111/j.1600-6143.2007.02118.x.

13.

Defining the canonical form of T-cell-mediated rejection in human kidney transplants.

Famulski KS, Einecke G, Sis B, Mengel M, Hidalgo LG, Kaplan B, Halloran PF.

Am J Transplant. 2010 Apr;10(4):810-20. doi: 10.1111/j.1600-6143.2009.03007.x. Epub 2010 Feb 3.

14.

Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies.

Halloran PF, Reeve JP, Pereira AB, Hidalgo LG, Famulski KS.

Kidney Int. 2014 Feb;85(2):258-64. doi: 10.1038/ki.2013.300. Epub 2013 Aug 21. Review.

15.

Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.

Sarwal M, Chua MS, Kambham N, Hsieh SC, Satterwhite T, Masek M, Salvatierra O Jr.

N Engl J Med. 2003 Jul 10;349(2):125-38.

16.

Molecular phenotypes of acute kidney injury in kidney transplants.

Famulski KS, de Freitas DG, Kreepala C, Chang J, Sellares J, Sis B, Einecke G, Mengel M, Reeve J, Halloran PF.

J Am Soc Nephrol. 2012 May;23(5):948-58. doi: 10.1681/ASN.2011090887. Epub 2012 Feb 16.

17.

Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches.

Reeve J, Einecke G, Mengel M, Sis B, Kayser N, Kaplan B, Halloran PF.

Am J Transplant. 2009 Aug;9(8):1802-10. doi: 10.1111/j.1600-6143.2009.02694.x. Epub 2009 Jun 10.

18.

Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts.

Mengel M, Reeve J, Bunnag S, Einecke G, Sis B, Mueller T, Kaplan B, Halloran PF.

Am J Transplant. 2009 Jan;9(1):169-78. doi: 10.1111/j.1600-6143.2008.02462.x. Epub 2008 Oct 31.

19.

The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables.

Mengel M, Sis B, Kim D, Chang J, Famulski KS, Hidalgo LG, Einecke G, de Freitas DG, Tymchak W, Burton J, Halloran PF.

Am J Transplant. 2010 Sep;10(9):2105-15. doi: 10.1111/j.1600-6143.2010.03182.x.

20.

The early course of kidney allograft rejection: defining the time when rejection begins.

Einecke G, Mengel M, Hidalgo L, Allanach K, Famulski KS, Halloran PF.

Am J Transplant. 2009 Mar;9(3):483-93. doi: 10.1111/j.1600-6143.2008.02546.x.

Supplemental Content

Support Center